Albert Borla

Bullish

3

Radar Rating

Average

5-dimension analyst performance assessment

Volume

1

Diversity

2

Consistency

10

Conviction

1

Recency

1

1analiz

Total Analyses

1

Buy

1

Sell

0

Hold

0

Unique Assets

1

Active Days

85+

International Stocks

Buy

The CEO evaluates the company's clinical trials for the obesity market and the sustainability of the dividend policy despite patent expirations.

A

Albert Borla85d

* Does not constitute investment advice